National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Ewing Family of Tumors Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 06/04/2008



Purpose of This PDQ Summary






General Information






Cellular Classification







Stage Information






Treatment Option Overview






Ewing Tumor of Bone: Localized Tumors






Ewing Tumor of Bone: Metastatic Tumors






Ewing Tumor of Bone: Recurrent Tumors






Get More Information From NCI






Changes to This Summary (06/04/2008)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Stage Information

For patients with confirmed Ewing tumor of bone (ETB), pretreatment staging studies should include magnetic resonance imaging (MRI) and/or computed tomography (CT) scan of the primary site, depending on the site. Despite the fact that CT and MRI are both equivalent in terms of staging, use of both imaging modalities may help radiation therapy planning.[1] Additional pretreatment staging studies should include bone scan, CT scan of the chest, and bone marrow aspiration and biopsy. Staging modalities under evaluation but not required on current clinical trials include fluorodeoxyglucose positron emission tomography and molecular analysis of bone marrow for the presence of fusion transcript. In certain studies determination of pretreatment tumor volume is an important variable (Euro-Ewings 99).

For ETB, the tumor is defined as localized when, by clinical and imaging techniques, there is no spread beyond the primary site or regional lymph node involvement. Continuous extension into adjacent soft tissue may occur.

References

  1. Panicek DM, Gatsonis C, Rosenthal DI, et al.: CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group. Radiology 202 (1): 237-46, 1997.  [PUBMED Abstract]

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov